Judicial Review Without Participation

Artifact Context

In Food and Drug Administration v. R. J. Reynolds Vapor Co. (2025), the Supreme Court addressed a question that appears technical but carries broad institutional consequences: who may seek judicial review of agency action under a closed regulatory scheme. The case arose from the FDA’s denial of a manufacturer’s premarket tobacco product application under the Tobacco Control Act. Retailers that would have sold the product joined the manufacturer in challenging the denial.

The Court did not decide whether the FDA acted unlawfully. It did not revisit the substance of federal tobacco regulation. It resolved a narrower issue—whether retailers, though excluded from the FDA’s administrative process, qualify as “persons adversely affected” entitled to judicial review. That narrowing is formal. Its effects are institutional.

What the Court Decides

The majority holds that retailers economically harmed by the FDA’s denial may seek judicial review under 21 U.S.C. § 387l(a)(1). Drawing on administrative law precedent, the Court interprets “adversely affected” broadly. Retailers face lost sales and potential criminal liability if they sell unauthorized products; that exposure places them within the statute’s zone of interests.

The holding is statutory, not constitutional. The Court does not evaluate the legality of the FDA’s decision and does not alter the agency’s regulatory authority. It opens access to review without resolving what review will yield.

What the Decision Reallocates

The FDA’s premarket approval regime is a closed process. Manufacturers apply; the agency evaluates; third parties have no formal role. That structure remains intact at the administrative level. What changes is the trigger for judicial review. Parties excluded from the process may now initiate review after the fact.

Participation and review are separated. Courts are asked to assess agency action at the request of actors who never engaged the regulatory process Congress designed. This reallocation occurs without doctrinal innovation and without altering the substantive standard governing agency decisions.

Litigation as Governance

The practical consequence is a reduction in the cost of judicialization for regulated industries. Retailers and manufacturers may form coalitions to challenge denials, selecting venues favorable to their interests. Agency efforts to confine review to particular circuits or procedural pathways are weakened.

Delay becomes consequential. While review proceeds, regulatory outcomes remain unsettled. Products remain in limbo. Enforcement timelines stretch. Time operates as an implicit governance lever, redistributing advantage without explicit authorization.

The Dissent’s Warning

Justice Jackson’s dissent, joined by Justice Sotomayor, focuses on institutional design rather than economic harm. In her account, the zone-of-interests inquiry must center on the substantive provision allegedly violated. The Tobacco Control Act creates a bilateral approval process between manufacturer and agency. Retailers are excluded by design.

Allowing outsiders to challenge denials permits judicial review without administrative participation and invites venue manipulation through coalition litigation. The dissent does not argue that retailers lack injury. It argues that injury alone is insufficient to reopen a closed regulatory system.

The majority does not directly address that concern.

Fragmented Enforcement Without Resolution

The decision leaves legality unresolved and agency authority nominally intact. What changes is enforcement topology. Access to courts expands. Review becomes contingent on litigation capacity. Regulatory outcomes depend increasingly on where and how challenges are brought rather than on the administrative process itself.

This is not a policy judgment. It is a structural consequence of procedural design.

Institutional Treatment

The decision should not be read as a general expansion of standing or as approval of regulated conduct. It is a gateway precedent that alters the permeability of a closed regulatory regime. Its significance lies in how it redistributes access to judicial review and reshapes the relationship between administrative process and litigation.

Whether that permeability proves manageable or corrosive is a question the opinion leaves open.

Argument Spine (Layer 4)

  • Claim: The Court expands access to judicial review without expanding administrative participation.
  • Mechanism: Broad interpretation of “adversely affected” decouples review from process.
  • Reallocation: Litigation access and venue flexibility increase.
  • Temporal Effect: Delay functions as an implicit governance lever.
  • Dissent Signal: The dissent identifies risk of regulatory scheme erosion.
  • Boundary: The decision resolves access, not legality or policy.